BeOne Medicines Announces $300M Expansion Of Its Manufacturing And R&D Center In New Jersey; Total U.S. Manufacturing Investment Reaches $1B+
The expansion will increase BeOne's production capacity to manufacture its medicines and is expected to create approximately 120 new full-time jobs. The investment supports the continued advancement of BeOne's
BeOne Medicines is spending $300 million to build bigger factories and research labs in New Jersey, which means they can make more medicine and hire more workers. When a company invests heavily in making stuff, it shows they believe their business will grow—watch to see if their medicine sales actually increase over time.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.